Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.

Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...

Huntington’s disease can drain energy in many ways. Pacing yourself, eating enough, staying safely active, getting good sleep, and asking your care team about treatable symptoms can help.

Huntington’s disease is a brain condition caused by a gene mutation. It typically develops between 30 and 50 years of age and causes movement issues such as chorea (involuntary dance-like movements), ...

Once upon a time, Teva Pharmaceutical Industries Ltd. (TEVA +1.23%) was a stock that many investors didn't want to touch with ...

After losing the top spot in March to Johnson & Johnson’s immunology drug Tremfya, AbbVie’s rival med Skyrizi is back as the drug with the highest level of ad spending. | After losing the top spot in ...

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

Neurocrine Biosciences, Inc.  today announced the presentation of new data from a clinician survey highlighting the functional impact experienced by patients with mild tardive dyskinesia (TD) severity ...

New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood ...

New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of ageThe d ...

Regular HDBuzz readers may recall our September 2024 article examining the long history of pridopidine in Huntington’s ...